Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy: A dual approach for triple-negative breast cancer treatment
Authors:
Open Access
- 24 January 2025
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 379, 621-635
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Gent (2021.01773)
- Carlos III Health Institute (PI22/01253)
- Foundation for Science and Technology (POCI-01-0145-FEDER-31859/2017, PTDC/MED-ONC/4165/2021, DL 57/2016/CP1360/CT0009)
- European Regional Development Fund
- Ministerio de Ciencia, Innovación y Universidades
- Chartered Institute of Management Accountants
- Universidad de Navarra (CEECIND/00697/2018, RYC2022-038084-I)
- European Commission (2021.01773, PI22/01253)
- European Cooperation in Science and Technology (CA21135)
This publication has 53 references indexed in Scilit:
- Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancerBiomaterials, 2020
- Enhanced Prevention of Breast Tumor Metastasis by Nanoparticle‐Delivered Vitamin E in Combination with Interferon‐GammaAdvanced Healthcare Materials, 2020
- Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacityActa Biomaterialia, 2017
- An interferon-γ-delivery system based on chitosan/poly(γ-glutamic acid) polyelectrolyte complexes modulates macrophage-derived stimulation of cancer cell invasion in vitroActa Biomaterialia, 2015
- Biosynthesis of highly pure poly-γ-glutamic acid for biomedical applicationsJournal of Materials Science: Materials in Medicine, 2012
- The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathwayBiomaterials, 2011
- Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapyBiomaterials, 2011
- Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophagesInternational Journal of Cancer, 2009
- Interferon‐γ Therapy: Evaluation of Routes of Administration and Delivery SystemsJournal of Pharmaceutical Sciences, 2002
- Tumor Cell Killing and Cytostasis by C3H/HeJ Macrophages Activated In Vitro by Lipid A-Associated Protein and Interferon GammaJournal of Leukocyte Biology, 1988